Atlas Trials

UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly

Clinical trial NCT05565521 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05565521
Sponsor
Sunnybrook Health Sciences Centre
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma Multiforme, AdultGlioblastoma, IDH-mutant
Start date
2022-12-13
Primary completion
2027-12-31
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.